# Entasis Therapeutics Holdings Inc. (ETTX)

Source: https://www.quantisnow.com/company/ETTX
Generated: 2026-11-17T13:53:34.677Z

- Ticker: ETTX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2018
- Website: entasistx.com

## About

Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant gram-negative bacteria in the United States. Its lead product candidate is sulbactam-durlobactam (SUL-DUR), a novel IV antibiotic that is in Phase III clinical trial for the treatment of Acinetobacter baumannii. The company also develops Zoliflodacin, a novel orally administered molecule, which is in Phase III clinical trial for the treatment of uncomplicated gonorrhea; ETX0282CPDP, an oral drug that is in Phase I clinical trial for the treatment of urinary tract infections; and ETX0462, a drug candidate from NBP platform that is in pre-clinical stage for the treatment of multidrug-resistant gram-negative infections. The company has a license and collaboration agreement with Zai Lab (Shanghai) Co., Ltd. for the development of durlobactam and SUL-DUR; and collaboration agreement with Global Antibiotic Research and Development Partnership for the development and commercialization of a product candidate containing zoliflodacin. Entasis Therapeutics Holdings Inc. was founded in 2015 and is headquartered in Waltham, Massachusetts.

## Latest ETTX news and filings

- 2022-10-12 12:30 UTC [Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022](https://www.quantisnow.com/insight/entasis-therapeutics-a-wholly-owned-subsidiary-of-innoviva-announces-data-3521666)
- 2022-07-21 21:27 UTC [SEC Form 15-12G filed by Entasis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-entasis-therapeutics-holdings-inc-3172358)
- 2022-07-14 12:15 UTC [Market Insight] [Over $42 Million Bet On This Biotechnology Stock? 4 Penny Stocks Insiders are Buying](https://www.quantisnow.com/insight/over-42-million-bet-on-this-biotechnology-stock-4-penny-3141684)
- 2022-07-14 01:27 UTC [SEC Form 4] [SEC Form 4: Innoviva, Inc. bought $42,395,047 worth of shares (19,270,476 units at $2.20)](https://www.quantisnow.com/insight/sec-form-4-innoviva-inc-bought-42395047-worth-of-shares-3140438)
- 2022-07-13 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Entasis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-entasis-therapeutics-holdings-inc-3135866)
- 2022-07-13 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Entasis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-entasis-therapeutics-holdings-inc-3135857)
- 2022-07-13 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Entasis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-entasis-therapeutics-holdings-inc-3135846)
- 2022-07-13 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Entasis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-entasis-therapeutics-holdings-inc-3135840)
- 2022-07-11 21:27 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Entasis Therapeutics Holdings Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-entasis-therapeutics-holdings-inc-3129461)
- 2022-07-11 21:18 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Entasis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-entasis-therapeutics-holdings-inc-3129409)
- 2022-07-11 21:18 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Entasis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-entasis-therapeutics-holdings-inc-3129400)
- 2022-07-11 21:17 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Entasis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-entasis-therapeutics-holdings-inc-3129393)
- 2022-07-11 21:16 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Entasis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-entasis-therapeutics-holdings-inc-3129388)
- 2022-07-11 21:15 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Entasis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-entasis-therapeutics-holdings-inc-3129376)
- 2022-07-11 21:14 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Entasis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-entasis-therapeutics-holdings-inc-3129367)
- 2022-07-11 21:13 UTC [SEC Form POS AM filed by Entasis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-entasis-therapeutics-holdings-inc-3129352)
- 2022-07-11 21:12 UTC [SEC Form POS AM filed by Entasis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-entasis-therapeutics-holdings-inc-3129351)
- 2022-07-11 21:12 UTC [SEC Form POS AM filed by Entasis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-entasis-therapeutics-holdings-inc-3129341)
- 2022-07-11 21:08 UTC [SEC Form POS AM filed by Entasis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-entasis-therapeutics-holdings-inc-3129312)
- 2022-07-11 21:02 UTC [SEC Form 8-K] [Entasis Therapeutics Holdings Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/entasis-therapeutics-holdings-inc-filed-sec-form-8-k-termination-of-3129276)
- 2022-07-11 20:11 UTC [SEC Form 4] [SEC Form 4: Wagner Kristie Ann returned 80,500 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-wagner-kristie-ann-returned-80500-shares-to-3128751)
- 2022-07-11 20:10 UTC [SEC Form 4] [SEC Form 4: Triola Anna Diaz returned 125,000 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-triola-anna-diaz-returned-125000-shares-to-3128746)
- 2022-07-11 20:09 UTC [SEC Form 4] [SEC Form 4: Tommasi Ruben returned 150,000 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-tommasi-ruben-returned-150000-shares-to-the-3128745)
- 2022-07-11 20:09 UTC [SEC Form 4] [SEC Form 4: Ronsheim Matthew returned 150,000 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-ronsheim-matthew-returned-150000-shares-to-the-3128734)
- 2022-07-11 20:08 UTC [SEC Form 4] [SEC Form 4: Perros Manoussos returned 478,500 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-perros-manoussos-returned-478500-shares-to-the-3128728)
- 2022-07-11 20:07 UTC [SEC Form 4] [SEC Form 4: Mueller John Patrick returned 150,000 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-mueller-john-patrick-returned-150000-shares-to-3128726)
- 2022-07-11 20:07 UTC [SEC Form 4] [SEC Form 4: Meek David D. returned $60,500 worth of shares to the company (27,500 units at $2.20), closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-meek-david-d-returned-60500-worth-of-3128720)
- 2022-07-11 20:06 UTC [SEC Form 4] [SEC Form 4: Mayer Howard returned $60,500 worth of shares to the company (27,500 units at $2.20), closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-mayer-howard-returned-60500-worth-of-shares-3128714)
- 2022-07-11 20:06 UTC [SEC Form 4] [SEC Form 4: Keiley Elizabeth M returned 150,000 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-keiley-elizabeth-m-returned-150000-shares-to-3128708)
- 2022-07-11 20:05 UTC [SEC Form 4] [SEC Form 4: Hastings David C returned $60,500 worth of shares to the company (27,500 units at $2.20), closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-hastings-david-c-returned-60500-worth-of-3128687)
- 2022-07-11 20:04 UTC [SEC Form 4] [SEC Form 4: Berger Heather A. returned $60,500 worth of shares to the company (27,500 units at $2.20), closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-berger-heather-a-returned-60500-worth-of-3128685)
- 2022-07-11 20:03 UTC [SEC Form 4] [SEC Form 4: Altarac David returned 150,000 shares to the company, closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-altarac-david-returned-150000-shares-to-the-3128643)
- 2022-07-11 15:01 UTC [SEC Form 25-NSE filed by Entasis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-entasis-therapeutics-holdings-inc-3127414)
- 2022-07-08 21:04 UTC [SEC Form SC 13E3/A filed by Entasis Therapeutics Holdings Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-entasis-therapeutics-holdings-inc-3124434)
- 2022-07-08 21:00 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Entasis Therapeutics Holdings Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-entasis-therapeutics-holdings-inc-3124383)
- 2022-07-08 20:54 UTC [SEC Form SC 13E3/A filed by Entasis Therapeutics Holdings Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-entasis-therapeutics-holdings-inc-3124151)
- 2022-07-08 20:48 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by Entasis Therapeutics Holdings Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-entasis-therapeutics-holdings-inc-3124110)
- 2022-07-08 12:35 UTC [Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/innoviva-announces-expiration-of-cash-tender-offer-for-shares-of-3121657)
- 2022-07-01 00:29 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by Entasis Therapeutics Holdings Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-entasis-therapeutics-holdings-inc-3098024)
- 2022-06-17 12:11 UTC [SEC Form SC 13E3/A filed by Entasis Therapeutics Holdings Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-entasis-therapeutics-holdings-inc-3041834)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ETTX
- Earnings history: https://www.quantisnow.com/earnings/ETTX
- Dividend history: https://www.quantisnow.com/dividends/ETTX
- Insider transactions: https://www.quantisnow.com/insiders/ETTX
- Options chain: https://www.quantisnow.com/options/ETTX
- SEC 8-K filings only: https://www.quantisnow.com/company/ETTX/8-k
- RSS and alerts for ETTX: https://www.quantisnow.com/docs/rss-feeds.md
